BIOMAT Database Logo BIOMAT Database Logo

Proceedings: Monitoring of plasma levels in epileptic patients. 1976

S Garattini, and P L Morselli

UI MeSH Term Description Entries
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

S Garattini, and P L Morselli
[Monitoring of plasma diphenylhydantoin levels in epileptic patients].
May 1983, Boletin medico del Hospital Infantil de Mexico,
S Garattini, and P L Morselli
Monitoring drug noncompliance in epileptic patients: assessing phenobarbital plasma levels.
January 1985, Therapeutic drug monitoring,
S Garattini, and P L Morselli
Plasma level monitoring of oxcarbazepine in epileptic patients.
January 2000, Archives of medical research,
S Garattini, and P L Morselli
Plasma PIVKA-II levels in epileptic patients.
January 1990, Brain & development,
S Garattini, and P L Morselli
Factors influencing plasma phenobarbitone levels in epileptic patients.
October 1977, British journal of clinical pharmacology,
S Garattini, and P L Morselli
The distribution of plasma phenytoin levels in epileptic patients.
August 1970, Journal of neurology, neurosurgery, and psychiatry,
S Garattini, and P L Morselli
Distribution of plasma phenobarbital, diphenylhydantoin and primidone levels in epileptic patients.
January 1977, Folia psychiatrica et neurologica japonica,
S Garattini, and P L Morselli
Plasma levels of di-no-propylacetate and clonazepam in epileptic patients.
September 1977, International journal of clinical pharmacology and biopharmacy,
S Garattini, and P L Morselli
Compliance monitoring in epileptic patients.
July 1993, The Journal of the Association of Physicians of India,
S Garattini, and P L Morselli
The effects of phenobarbitone dose on plasma phenobarbitone levels in epileptic patients.
January 1976, Proceedings of the Australian Association of Neurologists,
Copied contents to your clipboard!